Analgesic Effect of Illiohypogastic & Ilioinguinal Nerve Block in TAVR - TF (Prospective Randomized Study) - Trial NCT06362915

Name: Clinical Trial NCT06362915
Creator: Ain Shams University
Keywords: Anesthesia, Local, Lidocaine, Phase 1/2, drug, clinical trial, Egypt

Access comprehensive clinical trial information for NCT06362915 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Ain Shams University and is currently Recruiting. The study focuses on Anesthesia, Local. Target enrollment is 52 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

NCT06362915

Phase 1/2

Recruiting

drug

Trial Details

ClinicalTrials.gov • NCT06362915

View on ClinicalTrials.gov

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Analgesic Effect of Illiohypogastic & Ilioinguinal Nerve Block in TAVR - TF (Prospective Randomized Study)

Study Focus

Disease/Condition

Anesthesia, Local

Drug/Device/Intervention

Lidocaine

Study Type

Interventional

Intervention Type

drug

Sponsor & Location

Primary Sponsor

Ain Shams University

Location

Cairo,Cairo, Egypt

Timeline & Enrollment

Phase

Phase 1/2

Start Date

Jan 02, 2024

End Date

Aug 30, 2024

Enrollment

52 participants

Primary Outcome

Extra Demand of sedation

Summary

The purpose of the study is to compare the effect of illiohypogastric and ilioinguinal nerve block with the local infiltration with lidocaine in patients undergoing TAVI

ICD-10 Classifications

Local anaesthetics

Anaesthetic, unspecified

Other and unspecified general anaesthetics

Poisoning: Local anaesthetics

Parenteral anaesthetics

Data Source

Registry

ClinicalTrials.gov

Trial ID

NCT06362915

Type

Non-Device Trial